Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial fn1fn1This study was supported by Genentech, Inc., South San Francisco, C (Q56945190)
Jump to navigation
Jump to search
scientific article published on 01 March 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial fn1fn1This study was supported by Genentech, Inc., South San Francisco, C |
scientific article published on 01 March 1998 |
Statements
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (English)
R M Califf
C B Granger
R Becker
R P Tracy
K S Pieper
A M Ross
S Roth
C Lambrew